Summary
Device records identify Ronin Surgical Corp. as labeler of the X7, report commercial distribution and premarket exemption, and assign product code HPP. FDA classifies HPP under 21 CFR 886.4335 as Class I and 510(k)-exempt, subject to exemption limitations. Device listing and exemption are not FDA clearance or approval. [2][6]
Device records also identify an earlier X6 model in commercial distribution. That database status does not establish continued availability of new X6 units from the current manufacturer catalog. [1]
FDA MAUDE contains X6 reports received in 2023 and 2025 describing patient burns during procedures. The 2023 voluntary report and manufacturer report describe the same event and should not be counted as separate incidents. The manufacturer reported its returned-device testing found performance within specification and disputed device causation. MAUDE reports do not independently establish causation, incidence, a defect or a recall, and these X6 reports are not attributed to the X7. [3][4][5]